Previous Close | 17.47 |
Open | 17.38 |
Bid | 0.01 x 1400 |
Ask | 19.28 x 800 |
Day's Range | 17.23 - 17.69 |
52 Week Range | 13.05 - 23.25 |
Volume | |
Avg. Volume | 1,564,756 |
Market Cap | 1.937B |
Beta (5Y Monthly) | 1.02 |
PE Ratio (TTM) | 18.80 |
EPS (TTM) | 0.93 |
Earnings Date | Nov 02, 2022 - Nov 07, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Oct 07, 2008 |
1y Target Est | 21.60 |
Subscribe to Yahoo Finance Plus to view Fair Value for MDRX
MDRX vs. OMCL: Which Stock Is the Better Value Option?
The average of price targets set by Wall Street analysts indicates a potential upside of 26.9% in AllScripts (MDRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Allscripts' (MDRX) robust Q2 results demonstrate strength in both segments.